Lilly drives expansion at Rexam's insulin pen manufacturing plant
Rexam says that expansion of its French plant is led by Lilly and the growing demand for insulin delivery products.
Archives for February 7, 2013
Uncertainties Abound in Indian Draft Clinical Trial Amendment
Proposed amendments to Indian clinical trial laws on compensation are confusing and potentially problematic for sponsors and CROs says ACRO.
QPS adds Phase I capacity in the US with MRA buy
QPS has acquired Florida-based trial site Miami Research Associates (MRA), adding first-in-man capacity to its US services offering.
Sun shines on FDA to expedite Doxil generic approval
Sun Pharma says it is confident that all quality issues are covered as its Doxil generic gets hurried approval from the FDA.
Novo Nordisk Says Warning Letter for Backup Plant Won’t Cause Insulin Shortages
In its third warning letter released this year for a foreign manufacturer, the FDA has warned Novo Nordisk for failing to follow procedures designed to prevent contamination. But the company downplayed the impact of the letter and said it won’t create...
CDSCO oversight plan for APIs shipped to EU published by Pharmexcil
An Indian export group has published what it claims are draft CDSCO guidelines setting out what API makers must do to comply with EU import rules that come into effect this summer.